0
0
0
0
1
2
3
$0
Is Verisign solid or fragile? The Finex Financial Health Scanner reads VRSN's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2025) | $1.7B |
|---|---|
| Net income | $825.7M |
| Operating margin | 67.7% |
| Net margin | 49.8% |
| Cash and investments | $580.5M |
| Total debt | $1.8B |
| Free cash flow | $800.4M |
| Revenue growth (1 year) | 6.4% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.